Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: A historical cohort

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 10, 2012, Pages 1299-1307

  Lieberman, J A ^a   Morotti, R A ^a   Konstantinou, G N ^a,b   Yershov, O ^a   Chehade, M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b 424 General Army Hospital   (Greece)

Author keywords

corticosteroids; diet; eosinophilic esophagitis; fibrosis; remodeling

Indexed keywords

AMINO ACID; BUDESONIDE; FLUTICASONE;

ABSCESS; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEGRANULATION; DIET RESTRICTION; EOSINOPHIL COUNT; EOSINOPHILIC ESOPHAGITIS; EPITHELIUM HYPERPLASIA; ESOPHAGEAL SUBEPITHELIAL FIBROSIS; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LAMINA PROPRIA; MAIZE; MALE; PATIENT COMPLIANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EOSINOPHILIC ESOPHAGITIS; EPITHELIUM; ESOPHAGUS; FEMALE; FIBROSIS; HUMANS; MALE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866461463     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02881.x     Document Type: Article

References (20)

1. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20.
2. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009; 48: 30-36.
3. Aceves SS, Newbury RO, Dohil MA, Bastian JF, Dohil R,. A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol 2009; 103: 401-406.
4. Dellon ES, Gibbs WB, Fritchie KJ, Rubinas TC, Wilson LA, Woosley JT, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009; 7: 1305-1313.
5. Lucendo AJ, Castillo P, Martin-Chavarri S, Carrion G, Pajares R, Pascual JM, et al. Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases. Eur J Gastroenterol Hepatol 2007; 19: 417-424. (Pubitemid 46596696)
6. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH,. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007; 119: 206-212. (Pubitemid 46037819)
7. Chehade M, Sampson HA, Morotti RA, Magid MS,. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007; 45: 319-328. (Pubitemid 47415083)
8. Korsapati H, Babaei A, Bhargava V, Dohil R, Quin A, Mittal RK,. Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis. Gut 2009; 58: 1056-1062.
9. Nurko S, Rosen R, Furuta GT,. Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol 2009; 104: 3050-3057.
10. Aceves SS, Chen D, Newbury RO, Dohil R, Bastian JF, Broide DH,. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol 2010; 126: 1198-1204.
11. Li-Kim-Moy JP, Tobias V, Day AS, Leach S, Lemberg DA,. Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2011; 52: 147-153.
12. Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65: 109-116.
13. Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010; 139: 1526-1537.
14. Abu-Sultaneh SM, Durst P, Maynard V, Elitsur Y,. Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis. Dig Dis Sci 2011; 56: 97-102.
15. Teitelbaum JE, Fox VL, Twarog FJ, Nurko S, Antonioli D, Gleich G, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002; 122: 1216-1225. (Pubitemid 34465163)
16. Dohil R, Newbury R, Fox L, Bastian J, Aceves S,. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139: 418-429.
17. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU,. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003; 125: 1660-1669. (Pubitemid 37500430)
18. Lucendo AJ, Arias A, De Rezende LC, Yague-Compadre JL, Mota-Huertas T, Gonzalez-Castillo S, et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol 2011; 128: 1037-1046.
19. Kagalwalla AF, Akhtar N, Woodruff SA, Rea BA, Masterson JC, Mukkada V, et al. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol 2012; 129: 1387-1396.
20. Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano I, et al. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012; 67: 477-490.